コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y, lung function, and airway responsiveness (school age).
2 and asthma were collected when children were school age.
3 ne therapy is effective and safe into middle school age.
4 airway inflammation in asthmatic children at school age.
5 een specific modes of delivery and asthma at school age.
6 total IgE level or allergen sensitization at school age.
7 epression symptoms underwent neuroimaging at school age.
8 One patient had seizures only at school age.
9 age with cognitive and physical outcomes at school age.
10 y long-term benefit for visual processing at school age.
11 h the development of allergic diseases up to school age.
12 fe on the prevalence of allergic diseases at school age.
13 tein content reduces BMI and obesity risk at school age.
14 hology was examined in relation to asthma at school age.
15 children with family history of allergies at school age.
16 y inflammation, is associated with asthma at school age.
17 (ADHD) and impairment between preschool and school age.
18 erent respiratory/allergic phenotypes before school age.
19 lung volume growth in children of elementary-school age.
20 ween those who did or did not have asthma at school age.
21 ence the development of AD, asthma and AR at school age.
22 play in children's cognitive development at school age.
23 nt potential biomarkers of risk of asthma by school age.
24 ared to nonallergic children from infancy to school age.
25 s to promote early intervention beginning in school age.
26 sensitization increase the risk of asthma at school age.
27 in is rarely seen in youth before they reach school age.
28 terns of 60 candidate genes in boys at early school age.
29 n assessment of neurodevelopment at least to school age.
30 3 at age 5 years or less predicted asthma at school age.
31 dogenous DHA synthesis in infancy but not at school-age.
33 , 0.36-0.43) and of not completing secondary school (age 2 years: 0.74, 0.67-0.78; mid-childhood: 0.8
35 ods, surveys of children entering elementary school (age 5 years before Sept 1) allow assessment of s
38 A total of 402 children were followed until school age (6-11 years) for the assessment of current at
39 d 31 weeks postpartum (infants), and once at school age (6-11 years), from 440 children (49.3% girls,
42 sociation between transient hypoglycemia and school-age achievement test proficiency based on perinat
44 or functional outcomes in their children at school age, although a mortality advantage cannot be exc
45 predicts the probability of having asthma at school age among preschool children with suggestive symp
46 sterone, DHEA, and hippocampal volume across school age and adolescence, and measures of emotion regu
48 measured using magnetic resonance imaging at school age and children's diagnosis of MDD any time afte
49 support on hippocampal volume growth across school age and early adolescence and suggest an early ch
53 early childhood impacts brain development at school age and to explore the mediators of this effect.
54 ing multiplex array among 509 adults and 140 school-age and 131 preschool children with asthma/wheeze
57 ze and cough at 2 time points (preschool and school age) and objective measurements of atopy, lung fu
58 titis was found in 50% of those diagnosed in school age, and persistent atopic dermatitis was signifi
61 tors associated with respiratory symptoms at school age are early respiratory problems, family histor
62 greater negative mood/depression severity at school age, as did connectivity between the left hippoca
63 ercury exposure with poorer performance on a school-age assessment of IQ, a measure whose relevance f
65 uramic acid related to a lower prevalence of school-age asthma (adjusted odds ratio, 0.59 [95% confid
68 ds ratio [pOR], 1.34; 95% CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95% CI, 1.18-1.67) indepen
69 eight gain, we observed the highest risks of school-age asthma in children born preterm with high inf
70 we performed epigenome-wide meta-analyses of school-age asthma in relation to CpG methylation (Illumi
74 This yielded prevalence estimates for FA in school age between 1.4% (88 related to all 6105 particip
76 omen, with or without routine vaccination of school-age boys, and for a 1-time catch-up vaccination o
79 of task-irrelevant VPL in healthy elementary school age children (7-10 years old) and compared their
82 A from mattress dust and nasal samples of 86 school age children was analyzed by 454 pyrosequencing o
86 Infection prevalence and intensity peaks in school age children: both reduced water contact and acqu
87 wth standards" and "WHO growth standards for school aged children and adolescents" for children up to
88 ication method ranged from 18.9% to 36.9% in school-age children (5-11 years) and from 16.6% to 35.8%
89 ncentrations among infants (6-23 mo of age), school-age children (6-8 y of age), and women (15-25 y o
90 39 preschool children (ages 3-6 yr), and 38 school-age children (7-16 yr) with CF before chest compu
93 r study was to evaluate the iodine intake of school-age children and adolescents, using UIE measureme
94 y greatly across subgroups, being highest in school-age children and adults (18.3%, CI 9.4%-28.2%, an
95 2009 pandemic could have a modest impact on school-age children and adults in terms of IPD and a sma
96 or Affective Disorders and Schizophrenia for School-Age Children and functioning assessed by the Chil
100 d on 3 bilateral basal ganglia structures in school-age children chronically exposed to Mn through dr
101 ic vaccination campaign targeting adults and school-age children could have mitigated or prevented th
102 for the obstructive sleep apnea syndrome in school-age children did not significantly improve attent
103 sylation was analysed in serum/plasma of 700 school-age children from different communities of Gabon,
106 exposure on various respiratory outcomes in school-age children generally representative of the popu
107 a panel study in a representative sample of school-age children in the two major cities of Greece, A
108 his study, blood samples were collected from school-age children in Western Kenya, in the form of bot
109 he findings underline the critical role that school-age children play in facilitating the geographic
110 or Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime version (K-SADS
111 d with children without a history of PO MDD, school-age children previously diagnosed as having PO MD
113 on or P. falciparum infection in infants and school-age children resulted in significantly lower ID p
114 ms of the study were to assess chronotype in school-age children using a novel integrative measuremen
117 This is a retrospective study of sixty-six school-age children who received overnight orthokeratolo
118 ical and vascular foveal structures in early school-age children who were born premature were differe
119 imed to examine patterns of dysconnection in school-age children with ASD and ADHD and typically deve
121 tion was significantly higher in infants and school-age children with either inflammation or P. falci
124 e purpose of the current study was to assess school-age children's multitasking abilities during degr
126 dren younger than 5 years, 22.2-25.9 million school-age children, and 16.5-21.1 million adolescents w
131 district from 10% to 75% coverage of at-risk school-age children, the cost-effectiveness in terms of
133 or Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version intervi
141 [0.5%] exposed to farm animals) and 276,298 school-aged children (22,629 [8.2%] exposed to dogs and
143 st effective compared with treatment of only school-aged children (ICER $167 per DALY averted) and WH
144 ssociated with a decreased risk of asthma in school-aged children (OR, 0.87; 95% CI, 0.81-0.93) and i
147 of antimalarial treatment among asymptomatic school-aged children aged 5-15 years in sub-Saharan Afri
148 alaria infection in sub-Saharan Africa among school-aged children aged 5-15 years is underappreciated
149 reatment costs were estimated at US$0.74 for school-aged children and $1.74 for preschool-aged childr
151 ion (95% CrI 121 million to 125 million) for school-aged children and 247 million (239 million to 256
152 sentially uncharted, and existing studies in school-aged children and adolescents are confounded grea
153 brief counseling, to prevent tobacco use in school-aged children and adolescents have a moderate net
154 re interventions for tobacco cessation among school-aged children and adolescents who already smoke,
160 rs of reading skills have been identified in school-aged children and adults; many pertain to the pre
161 rrent diagnosis of asthma at age 6 years for school-aged children and as the hazard ratio (HR) for in
163 ducing P falciparum infection and anaemia in school-aged children and lowering parasite transmission.
164 ciated with a reduced risk of asthma in both school-aged children and preschool-aged children (OR, 0.
165 h 75% coverage in only school-aged children; school-aged children and preschool-aged children; adults
166 life circumstances of a community sample of school-aged children and then followed these children fo
167 y rate relative to baseline were greatest in school-aged children and young adults, with no evidence
168 is was highly cost-effective in treatment of school-aged children at a prevalence of 20% (95% UI 5.4-
169 is was highly cost-effective in treatment of school-aged children at a prevalence threshold of 5% (95
173 or socioeconomic status (Health Behaviour in School-aged Children Family Affluence Scale) and health
175 It is estimated that vaccinating 50%-70% of school-aged children for influenza can produce populatio
176 kworm, A lumbricoides, and T trichiura among school-aged children from 2000 onwards was 16.5%, 6.6%,
177 ross-sectional survey was carried out on 693 school-aged children from 5 schistosomiasis-endemic vill
178 cted from 4512 ethnically diverse, nonmyopic school-aged children from grades 1 through 8 (baseline g
179 research summer camp program for low-income, school-aged children from July 1, 1986, to August 15, 20
183 ysis sheds quantitative light on the role of school-aged children in measles cross-scale dynamics, as
184 l exposure samples (n = 249) of 62 asthmatic school-aged children in Montreal were collected over 10
189 transmitted helminthiasis when prevalence in school-aged children is at or above a threshold of 50% a
191 he basis of WHO guidelines (treatment of all school-aged children once per year where prevalence in t
195 nalysis of data from the Health Behaviour in School-aged Children study, in which cross-sectional sur
196 is associated with allergic sensitization in school-aged children suggesting systemic low-grade infla
197 rtance of regular screening of preschool and school-aged children to reduce the development and progr
199 cRCT in closely connected communities where school-aged children were vaccinated: 60% (95% confidenc
200 to improved adherence and asthma outcomes in school-aged children who presented to the emergency depa
201 iles of 655 participants (n = 601 adults and school-aged children with asthma and 54 preschool childr
206 tion concentrated on a small area, including school-aged children with low background incidence of ca
207 Suicide is a leading cause of death among school-aged children younger than 12 years but little is
210 t included 17,696 children aged <5 y, 25,508 school-aged children, 28,328 adolescents, 89,164 adults,
211 udies were, however, performed in adults and school-aged children, and only a little is known about h
212 and individual levels in children <5 y old, school-aged children, and women of reproductive age.
213 doses against hookworm infections in African school-aged children, key information for the developmen
216 parasitic infections emphasise treatment of school-aged children, using separate treatment guideline
219 ers, counterintuitively, perform better than school-aged children, who in turn perform better than ad
220 Zika vaccination (women of childbearing age, school-aged children, young adults, and everyone) and th
246 on between gestational age and 4 outcomes in school-aged children: readiness to enter kindergarten, s
247 reatment programme with 75% coverage in only school-aged children; school-aged children and preschool
248 th adverse neurodevelopmental outcomes among school-aged children; yet, few studies have evaluated pr
249 In countries with no pertussis booster until school age, continued monitoring of protection against p
250 rvivors available for follow-up, outcomes at school age (corrected age 6-11 years) were determined fo
252 l connectivity in a well-controlled group of school-aged EPT children with no known brain injury or n
254 iota of 327 throat and 68 nasal samples from school-age farm and nonfarm children were analyzed by 45
255 s isolated from a PEODDN lesion of a primary school-aged female patient with bands of hyperkeratotic-
256 total of 6105 children participated in this school-age follow-up (57.8% of 10 563 recruited at birth
257 from the 14 centers who participated in the school-age follow-up (n = 443 magnesium; n = 424 placebo
258 hood materially impacts brain development at school age further underscores the importance of attenti
259 gnetic resonance imaging (fMRI) data from 68 school-aged girls, along with social network information
260 antly increased risk of developing asthma by school age (>/=2 biomarkers vs none: OR, 6.6; 95% CI, 2.
261 n early childhood, although its effects into school age have not been reported from randomized trials
264 il thickening and plantar keratoderma before school age in more than three-quarters of affected child
265 ple and robust tool for predicting asthma at school age in preschool children with wheeze or cough.
266 d gut microbiota development from infancy to school age in relation to onset of IgE-associated allerg
267 mpus and amygdala and a number of regions at school age, including the superior frontal cortex, lingu
268 p < 0.001) in 2017-2018 among non-elementary-school-aged individuals and -73 (95% CI -147, 1; p = 0.0
271 vel modeling of the effects of preschool and school-age maternal support on hippocampal volumes acros
273 uring pregnancy, cord blood, and children at school age (median age, 7.7 years; interquartile range,
275 .001, n = 618) and reduced risk of asthma at school age (odds ratio (OR) = 0.72 (0.56-0.93), P = 0.01
276 0% reduced odds of ever allergic rhinitis at school age (odds ratios of 0.79 [95% CI, 0.67-0.92] and
277 set remitting, midchildhood-onset remitting, school age-onset persisting, late childhood-onset persis
279 tion in childhood protects against asthma at school age partially by means of higher intake of omega-
282 ng >=3 were at high risk of having asthma at school-age (PPV > 75%; +LR 6.3, -LR 0.6), whereas childr
285 rrelates of attention and memory deficits in school-age survivors of neonatal extracorporeal membrane
286 was inversely associated with HT; c-BMI from school age to adulthood and c-height from birth to schoo
287 live at randomization, the mortality rate to school age was 14% (88/629) in the magnesium sulfate gro
288 leanliness and allergic health conditions at school age was collected in 399 participants of the urba
292 age to adulthood and c-height from birth to school age were positively associated with hypertension.
293 children who participated in neuroimaging at school age were used to investigate the effects of pover
294 regnant mothers, cord blood, and children at school age were weak to moderate (r = -0.03 to 0.53).
295 tive biomarkers of anxiety are needed before school age when anxiety symptoms typically consolidate i
297 n impact on functional brain connectivity at school age, which in turn mediates influences on child n
298 easures of respiratory/allergic morbidity at school age, while children breastfed for at least 3 mont